Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$30.58 -0.17 (-0.55%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Total Current Liabilities (2013 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) recorded Total Current Liabilities of $117.57 million in the quarter ended Mar 31, 2026, down 74.4% from $459.72 million a year earlier and down 33.9% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Total Current Liabilities (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics reported Total Current Liabilities of $172.71 million, down 52.4% from the prior year.

  • Annual Total Current Liabilities has declined for five straight years, with a five-year compound annual growth rate of -81.1% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Total Current Liabilities came in at $362.67 million in the year ended Dec 31, 2024 (-21.3%), $460.74 million in the year ended Dec 31, 2023 (-99.9%), $550.73 billion in the year ended Dec 31, 2022 (-17.8%) and $670.36 billion in the year ended Dec 31, 2021 (-7.6%).
  • The figure for the quarter ended Mar 31, 2026 is the lowest quarterly Total Current Liabilities since the quarter ended Dec 31, 2016.
  • On a year-over-year basis, Total Current Liabilities rose in two of the last six quarters, with an average decline of 24.2%.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 11.1% in the quarter ended Sep 30, 2025, against a decline of 99.9% in the quarter ended Dec 31, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $177.94 million (quarter ended Dec 31, 2025), $428.53 million (quarter ended Sep 30, 2025) and $456.13 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Lakefront Biotherapeutics 2.01 Bn 2.01 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 115.09 Mn
Dec 31, 2025 179.57 Mn
Sep 30, 2025 430.03 Mn
Jun 30, 2025 472.56 Mn
Mar 31, 2025 473.05 Mn
Dec 31, 2024 348.69 Mn
Sep 30, 2024 392.32 Mn
Mar 31, 2024 412.58 Mn
Dec 31, 2023 473.97 Mn
Sep 30, 2023 469.01 Mn
Mar 31, 2023 570.21 Mn
Dec 31, 2022 557.06 Mn
Mar 31, 2022 628.30 Mn
Dec 31, 2021 641.53 Mn
Jun 30, 2021 686.72 Mn
Dec 31, 2020 781.38 Mn
Jun 30, 2020 695.68 Mn
Mar 31, 2020 686.79 Mn
Dec 31, 2019 640.54 Mn
Sep 30, 2019 690.81 Mn
API Access

Lakefront Biotherapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=LKFT&period=max&api_key=YOUR_API_KEY